Oncolytic Virus Therapies Market Report mainly improves market size,and provide detailed product mapping and investigation of various market scenarios. Our expert analysts provide a thorough analysis and breakdown of the market presence of key market leaders. We strive to stay updated with the recent developments and follow the latest company news related to the industry players operating in the global Oncolytic Virus Therapies market. This helps us to comprehensively analyze the individual standing of the companies as well as the competitive landscape. Our vendor landscape analysis offers a complete study to help you gain the upper hand in the competition.
Get a Free sample of the report : https://www.emergenresearch.com/request-sample/704
Rise in number of research institutes for development of effective therapies and drugs to treat and study cancer, particularly in developing countries, is driving the growth of cancer research institute segment. Increased investment by private and government sectors into these institutions is driving segment growth.
North America accounted for the largest revenue share in 2020. The U.S. is the primary contributor and is expected to witness high growth due to the large amount of funding by the private firms and government for clinical trials. Other factors driving the oncolytic virus therapies market are an increase in research and development initiatives to develop therapeutic options for chronic diseases, easy approval for clinical trials, and availability of highly sophisticated research infrastructure.
Key players in the market include Oncolytics Biotech, Inc., Amgen Inc., Sorrento Therapeutics, Inc., Transgene SA, Daiichi Sankyo Company, Limited, Shanghai Sunway Biotech Co., Ltd., Takara Bio Inc., PsiOxus Therapeutics, SillaJen, Inc., and ViroCure.
Oncolytic virus is a virus which infects and kills cancer cells and as these cancer cells are destroyed by oncolysis, they release new infectious particles which destroy remaining tumor. Cancer mortality rate is 158.3 per 100,000 people per year. Estimated national expense for cancer in the U.S. was USD 150.8 billion in 2018. This cost is likely to increase as population ages and need for development of new effective therapies will fuel oncolytic virus therapies market growth.
The latest report is the most recent study that offers 360° coverage of the Oncolytic Virus Therapies industry that has been facing the brunt of the adverse economic impact of the COVID-19 outbreak since the beginning of this year. The global health crisis has affected nearly every aspect of the business vertical and led to massive disruptions to the global Oncolytic Virus Therapies market demand and supply chains. Researchers draw predictions for the market scenario in the post-COVID era. The report, additionally, assesses the present market situation and estimates its future outcomes, keeping in mind the impact of the pandemic on the global economic landscape.
Various awareness campaigns are being conducted to encourage people to opt for early diagnosis which will increase the patient pool of oncolytic virus therapy. However, there are some common side-effects of the therapy, which include chills, nausea, fatigue, fever, flu-like symptoms, and injection site pain. This hinders oncolytic virus therapies market revenue growth.
The report offers a comprehensive overview of the competitive landscape and covers company profiles, production and manufacturing capacity, product portfolio, expansion strategies, and business initiatives such as mergers and acquisitions, joint ventures, collaborations, partnerships, and product launches and brand promotions among others.
Request customization of the report: https://www.emergenresearch.com/request-for-customization/704
Emergen Research has segmented the global oncolytic virus therapies market on the basis of virus type, application, end-use, and region:
Virus Type Outlook (Revenue, USD Million; 2018–2028)
- Genetically Engineered Oncolytic Viruses
- Herpes Simplex Virus
- Vaccinia Virus
- Oncolytic Wild-Type Viruses
- Newcastle Disease Virus
- Vesicular Stomatitis Virus
Application Outlook (Revenue, USD Million; 2018–2028)
- Solid Tumors
- Breast Cancer
- Prostate Cancer
- Lung Cancer
- Hematological Malignancies
End-use Outlook (Revenue, USD Million; 2018–2028)
- Specialty Clinics
- Cancer Research Institute
The global Oncolytic Virus Therapies market has been categorized on the basis of key geographical regions into North America, Asia Pacific, Europe, Latin America, and Middle East Africa. It evaluates the presence of the global Oncolytic Virus Therapies market in the major regions with regards to market share, market size, revenue contribution, sales network and distribution channel, and other key elements.
Key questions addressed in the report:
What are the key factors driving the global Oncolytic Virus Therapies market?
Who are the key manufacturers in this market space?
Who are the distributors, traders and dealers of this market?
What are the market opportunities and risks affecting the performance of the vendors in the global Oncolytic Virus Therapies market?
What are the sales and revenue estimations for the top manufacturers in this market over the projected timeline?
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756